Encompass Health (NYSE:EHC) Announces Quarterly Earnings Results, Beats Estimates By $0.12 EPS

Encompass Health (NYSE:EHC) released its quarterly earnings results on Thursday. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12, Zacks reports. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. Encompass Health updated its FY 2025 guidance to 4.670-4.960 EPS.

Encompass Health Price Performance

Shares of NYSE:EHC traded up $1.03 during trading on Friday, reaching $99.63. 524,866 shares of the company’s stock traded hands, compared to its average volume of 637,634. The firm has a market cap of $10.04 billion, a PE ratio of 24.05, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a fifty-two week low of $72.37 and a fifty-two week high of $104.55. The company has a 50-day simple moving average of $96.34 and a 200-day simple moving average of $95.10. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Analysts Set New Price Targets

A number of research analysts recently weighed in on EHC shares. KeyCorp lifted their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday. Barclays lifted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada upped their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.